Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.Genome Medicine|September 22, 2018
Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cellsCherry S Leung, Kevin Y Yang, Xisheng Li, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.Blood|April 20, 2004
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administrationGeoff Hale, Peppy Rebello, Lee R Brettman, et al.The Journal of Experimental Medicine|July 8, 2018
Foxp3<sup>+</sup> T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8<sup>+</sup> T cell responseKrista Stockenhuber, Ahmed N Hegazy, Nathaniel R West, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.JCI Insight|February 15, 2017
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Stephen Paul Cobbold, Elizabeth Adams, et al.Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.Cell Reports|August 9, 2018
Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 DiabetesOscar M Leung, Jiatao Li, Xisheng Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
A novel strategy to reduce the immunogenicity of biological therapiesJennifer Somerfield, Grant A Hill-Cawthorne, Andrew Lin, et al.Pageof 15